Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Jan 19:39:5.
doi: 10.1186/1824-7288-39-5.

Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers

Affiliations
Case Reports

Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers

Manuela Cerbone et al. Ital J Pediatr. .

Abstract

Subclinical hypothyroidism (SH) is a condition characterized by a mild persistent thyroid failure. The main cause is represented by autoimmune thyroiditis, but mutations in genes encoding proteins involved in TSH pathway are thought to be responsible for SH, particularly in cases arising in familial settings. Patients with the syndrome of TSH unresponsiveness may have compensated or overt hypothyroidism with a wide spectrum of clinical and morphological alterations depending on the degree of impairment of TSH-receptor (TSH-R) function. We describe the case of two brothers with non autoimmune SH carrying the same heterozygous mutation in the extracellular domain of TSH-R and presenting with different clinical, biochemical and morphological features. The first one had only a slight persistent elevation of TSH, a normal thyroid ultrasound and did never require l- thyroxine (L-T4) replacement treatment. The second one had a neonatal persistent moderate TSH levels increase associated with a thyroid gland hypoplasia and was treated with L-T4 since the first months of life.These two cases support the recent association of TSH-R mutations inheritance as an autosomal dominant pattern with variable expressivity and suggest that the decision to start replacement therapy in patients with persistent SH due to TSH resistance should be individualized.

PubMed Disclaimer

References

    1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228–238. doi: 10.1001/jama.291.2.228. - DOI - PubMed
    1. Biondi B. Natural history, diagnosis and management of subclinical thyroid disfunction. Best Pract Res Clin Endocrinol Metab. 2012;26:431–446. doi: 10.1016/j.beem.2011.12.004. - DOI - PubMed
    1. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr. 2006;6:12. doi: 10.1186/1471-2431-6-12. - DOI - PMC - PubMed
    1. Paolo Valeri M, Maman-Alvardo D, Mayor G, Ridgway EC. Frequency of subclinical hypothyroidism among healthy children and those with neurological conditions in the state of Merida, Venezuela. Invest Clin. 2000;44:209–218. - PubMed
    1. Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, Salerno M, Cappa M, Baiocchi M, Gastaldi R, Minerba L, Loche S. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol. 2012;76:394–398. doi: 10.1111/j.1365-2265.2011.04251.x. - DOI - PubMed

Publication types